Esperion Therapeutics Inc
F:0ET
Esperion Therapeutics Inc
F:0ET
Price:
2.635
EUR
0.76%
Market Cap:
€495m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
2.6
Current
6%
More Expensive
vs 3-y average of 2.5
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
EV/S
=
2.6
Enterprise Value
/
€915.1m
Revenue
$403.1m
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
EV/S
=
2.6
Enterprise Value
/
€915.1m
Revenue
$403.1m
EV/S Valuation Scenarios
Esperion Therapeutics Inc is trading above its 3-Year Average
If EV/S returns to its 3-Year Average (2.5), the stock would be worth €2.48 (6% downside :side from current price).
Statistics
Positive Scenarios
3/4
Maximum Downside
-6%
Maximum Upside
+35%
Average Upside
15%
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.6 | €2.64 |
0%
|
| 3-Year Average | 2.5 | €2.48 |
-6%
|
| 5-Year Average | 3.1 | €3.09 |
+17%
|
| Industry Average | 3.6 | €3.56 |
+35%
|
| Country Average | 3 | €3.04 |
+15%
|
Forward EV/S
Today's price vs future Revenue
| Current Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
€915.1m
|
/ |
Dec 2025
$403.1m
|
= |
|
|
€915.1m
|
/ |
Dec 2026
$402.1m
|
= |
|
|
€915.1m
|
/ |
Dec 2027
$453.6m
|
= |
|
|
€915.1m
|
/ |
Dec 2028
$564.3m
|
= |
|
|
€915.1m
|
/ |
Dec 2029
$902.2m
|
= |
|
|
€915.1m
|
/ |
Dec 2030
$1.1B
|
= |
|
|
€915.1m
|
/ |
Dec 2031
$748.1m
|
= |
|
|
€915.1m
|
/ |
Dec 2032
$608.1m
|
= |
|
|
€915.1m
|
/ |
Dec 2033
$524.4m
|
= |
|
Forward EV/S shows whether today's EV/S still looks high or low once future Revenue are taken into account.
